February 2022 tender notification
Pharmac is pleased to provide the latest tender results.
Download the tender notification [PDF 114 KB]
Tender results
Pharmac has resolved to award tenders for Principal Supply Status for some products included in the 2020/21 Invitation to Tender, dated 2 November 2020 and the 2021/22 Invitation to Tender, dated 1 November 2021.
Some of the pharmaceuticals that will be delisted when the period of Principal Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. Pharmac will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.
Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to submit a Notification of Product Changes (NOPC) form to Pharmac, the Pharmacy Guild and the NZULM by:
- For new listings, by 4pm on 12 March 2022 or the 5th of the month prior to listing, whichever is earlier
- For price changes, by 4pm on the 12th of the month prior to the date of subsidy change
Pharmac cannot list a product (and pharmacies cannot claim) without this information.
More information about this process and NOPC forms can be found on our website.
Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand(external link) and that a CTPP code has been obtained from the New Zealand Universal List of Medicines(external link).
Pharmacodes and CTPP codes must be provided to Pharmac by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest).
Pharmac cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.
Correction to February 2022 Tender Notification
The February 2022 tender notification notified the incorrect subsidy/price change and Principal Supply dates for ‘methenamine (hexamine) hippurate – tab 1 g’.
The February 2022 notification also incorrectly omitted that Schedule 5, clause 3.1 (b) (ii) would apply to ‘pramipexole hydrochloride tab 0.25 mg and 1 mg’
Corrections in bold and strikethrough
2020/21 Tender – Principal Supply Status applies until 30 June 2024
Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule
1. Tenders awarded to currently listed Pharmaceuticals where at least one other brand is listed
|
Chemical name |
Presentation; |
Current |
New |
Principal Supply brand (Supplier) |
Date of listing |
Principal Supply Status date |
Brand (Supplier) affected by delisting |
|---|---|---|---|---|---|---|---|
|
Naloxone hydrochloride |
Inj 400 mcg per ml, 1 ml ampoule; 10 ampoule pack |
$22.60 (per 5) |
$35.26 (per 10) |
Hameln (Max Health) |
1 September 2022 |
1 February 2023 |
DBL Naloxone Hydrochloride (Pfizer) |
|
Ticagrelor |
Tab 90 mg; 56 tablet blister pack |
$90.00 |
$23.85 |
Ticagrelor Sandoz |
1 October 2022 |
1 March 2023 |
Brilinta (AstraZeneca) |
Hospital Pharmaceutical tenders – Section H of the Pharmaceutical Schedule.
The decisions were as follows:
2. Tenders awarded to currently listed Pharmaceuticals where at least one other brand is listed.
|
Chemical name |
Presentation; |
Current pack price |
New pack price |
Principal Supply brand |
DV limit |
Listing date |
Principal Supply date |
Brand (Supplier) affected by delisting |
|---|---|---|---|---|---|---|---|---|
|
Naloxone hydrochloride |
Inj 400 mcg per ml, 1 ml ampoule; 10 ampoule pack |
$22.60 (per 5) |
$35.26 (per 10) |
Hameln (Max Health) |
5% |
1 September 2022 |
1 February 2023 |
DBL Naloxone Hydrochloride (Pfizer) |
|
Ticagrelor |
Tab 90 mg; 56 tablet blister pack |
$90.00 |
$23.85 |
Ticagrelor Sandoz (Sandoz) |
5% |
1 October 2022 |
1 March 2023 |
Brilinta (AstraZeneca) |
2021/22 Tender – Principal Supply Status applies until 30 June 2025
Community Pharmaceutical tenders – Section B of the Pharmaceutical Schedule
3. Tenders awarded to currently listed Pharmaceuticals where no other brand is listed
|
Chemical name |
Presentation; |
Current |
New |
Principal Supply brand |
Date of subsidy change |
Principal Supply date |
|
|---|---|---|---|---|---|---|---|
|
Amiodarone hydrochloride1 |
inj 50 mg per ml, 3 ml ampoule; 10 ampoule |
$16.37 |
$15.22 |
Max Health (Max Health) |
1 July 2022 |
1 December 2022 |
|
|
Amiodarone hydrochloride |
Tab 100 mg; 30 tablet blister pack |
$3.80 |
$3.49 |
Aratac (Viatris) |
1 July 2022 |
1 December 2022 |
|
|
Amiodarone hydrochloride |
Tab 200 mg; 30 tablet blister pack |
$5.25 |
$4.49 |
Aratac (Viatris) |
1 July 2022 |
1 December 2022 |
|
|
Calcitriol |
Cap 0.25 mcg; 100 capsule bottle |
$7.95 |
$7.89 |
Calcitriol-AFT (AFT) |
1 July 2022 |
1 December 2022 |
|
|
Calcitriol |
Cap 0.5 mcg; 100 capsule bottle |
$13.75 |
$13.68 |
Calcitriol-AFT (AFT) |
1 July 2022 |
1 December 2022 |
|
|
Carbimazole |
Tab 5 mg; 100 tablet bottle |
$10.80 |
$7.56 |
Neo-Mercazole (AFT) |
1 April 2022 |
1 September 2022 |
|
|
Chloramphenicol1 |
Eye ointment 1%; 5 g tube OP |
$1.55 |
$1.09 |
Devatis (Devatis) |
1 July 2022 |
1 December 2022 |
|
|
Colchicine |
Tab 500 mcg; 100 tablet bottle |
$10.06 |
$6.00 |
Colgout (Aspen) |
1 April 2022 |
1 September 2022 |
|
|
Compound electrolytes1 |
Powder for oral soln; 50 sachet box |
$9.77 |
$9.53 |
Electral (Teva) |
1 July 2022 |
1 December 2022 |
|
|
Cyclizine lactate1 |
Inj 50 mg per ml, 1 ml ampoule; 10 ampoule |
$21.53 |
$16.36 |
Hameln (Max Health) |
1 July 2022 |
1 December 2022 |
|
|
Dihydrocodeine tartrate |
Tab long-acting 60 mg; 60 tablet bottle |
$8.60 |
$8.60 |
DHC Continus |
1 July 2022 |
1 December 2022 |
|
|
Dimethicone |
Crm 5% pump bottle; 500 ml OP |
$4.48 |
$4.30 |
healthE Dimethicone 5% |
1 July 2022 |
1 December 2022 |
|
|
Dimethicone |
Lotn 4%; 200 ml bottle OP |
$4.98 |
$4.25 |
healthE Dimethicone Lotion 4% (Jaychem) |
1 July 2022 |
1 December 2022 |
|
|
Erythromycin (as lactobionate) |
Inj 1 g; 1 vial pack |
$10.00 |
$10.00 |
Erythromycin IV (AFT) |
1 July 2022 |
1 December 2022 |
|
|
Glatiramer acetate1 |
Inj 40 mg prefilled syringe; 12 syringe pack |
$2,275.00 |
$1,137.48 |
Copaxone (Teva) |
1 May 2022 |
1 October 2022 |
|
|
Lisinopril1 |
Tab 5 mg; 90 tablet blister pack |
$17.50 |
$11.07 |
Ethics Lisinopril (Teva) |
1 May 2022 |
1 October 2022 |
|
|
Lisinopril1 |
Tab 10 mg; 90 tablet blister pack |
$17.50 |
$11.67 |
Ethics Lisinopril (Teva) |
1 May 2022 |
1 October 2022 |
|
|
Lisinopril1 |
Tab 20 mg; 90 tablet blister pack |
$17.50 |
$14.69 |
Ethics Lisinopril (Teva) |
1 May 2022 |
1 October 2022 |
|
|
Mercaptopurine |
Tab 50 mg; 25 tablet bottle |
$37.00 |
$25.90 |
Puri-nethol (Aspen) |
1 July 2022 |
1 December 2022 |
|
|
Methenamine (hexamine) |
Tab 1 g; 100 tablet bottle |
$40.01 |
$19.95 |
Hiprex (Radiant Health) |
1 April September 2022 |
1 September 2022 February 2023 |
|
|
Montelukast |
Tab 4 mg; 28 tablet blister pack |
$4.25 |
$3.10 |
Montelukast Mylan (Viatris) |
1 July 2022 |
1 December 2022 |
|
|
Montelukast |
Tab 5 mg; 28 tablet blister pack |
$4.25 |
$3.10 |
Montelukast Mylan (Viatris) |
1 July 2022 |
1 December 2022 |
|
|
Montelukast |
Tab 10 mg; 28 tablet blister pack |
$3.95 |
$2.90 |
Montelukast Mylan (Viatris) |
1 July 2022 |
1 December 2022 |
|
|
Olopatadine1 |
Eye drops 0.1%; 5 ml bottle OP |
$2.20 |
$2.17 |
Olopatadine Teva (Teva) |
1 July 2022 |
1 December 2022 |
|
|
Pramipexole hydrochloride1 |
Tab 0.25 mg; 100 tablet blister pack |
$6.12 |
$5.51 |
Ramipex (Devatis) |
1 July 2022 |
1 December 2022 |
|
|
Pramipexole hydrochloride1 |
Tab 1 mg; 100 tablet blister pack |
$20.73 |
$18.66 |
Ramipex (Devatis) |
1 July 2022 |
1 December 2022 |
|
|
Promethazine hydrochloride |
Tab 10 mg; 50 tablet blister pack |
$2.02 |
$1.39 |
Allersoothe (AFT) |
1 April 2022 |
1 September 2022 |
|
|
Promethazine hydrochloride |
Tab 25 mg; 50 tablet blister pack |
$2.27 |
$1.58 |
Allersoothe (AFT) |
1 April 2022 |
1 September 2022 |
|
|
Spironolactone |
Tab 25 mg; 100 tablet bottle |
$4.38 |
$3.68 |
Spiractin (Viatris) |
1 April 2022 |
1 September 2022 |
|
|
Spironolactone |
Tab 100 mg; 100 tablet bottle |
$11.80 |
$10.65 |
Spiractin (Viatris) |
1 April 2022 |
1 September 2022 |
|
|
1This product will be supplied at the Price from the 1st day of the month prior to the listing date, as per Schedule 5, clause 3.1 (b)(II) of the 2021/22 Invitation To Tender. |
|
||||||
Hospital Pharmaceutical tenders – Section H of the Pharmaceutical Schedule.
4. Tenders awarded to Pharmaceuticals where no other brand is listed
|
Chemical name |
Presentation; |
Current |
New |
Principal Supply brand |
DV |
Date of price change |
Principal Supply date |
|---|---|---|---|---|---|---|---|
|
Amiodarone hydrochloride2 |
Inj 50 mg per ml, 3 ml ampoule; 10 ampoule pack |
$16.37 |
$15.22 |
Max Health (Max Health) |
5% |
1 July 2022 |
1 December 2022 |
|
Amiodarone hydrochloride |
Tab 100 mg; 30 tablet blister pack |
$3.80 |
$3.49 |
Aratac (Viatris) |
5% |
1 July 2022 |
1 December 2022 |
|
Amiodarone hydrochloride |
Tab 200 mg; 30 tablet blister pack |
$5.25 |
$4.49 |
Aratac (Viatris) |
5% |
1 July 2022 |
1 December 2022 |
|
Bupivacaine hydrochloride with |
inj 0.5% with glucose 8%, |
$38.00 |
$26.67 |
Marcain Heavy (Aspen) |
5% |
1 April 2022 |
1 September 2022 |
|
Calcitriol |
Cap 0.25 mcg; 100 capsule bottle |
$7.95 |
$7.89 |
Calcitriol-AFT (AFT) |
5% |
1 July 2022 |
1 December 2022 |
|
Calcitriol |
Cap 0.5 mcg; 100 capsule bottle |
$13.75 |
$13.68 |
Calcitriol-AFT (AFT) |
5% |
1 July 2022 |
1 December 2022 |
|
Carmustine3 |
Inj 100 mg vial; 1 vial pack |
$1,387.00 |
$710.00 |
BiCNU (Luminarie) |
5% |
1 April 2022 |
1 September 2022 |
|
Chloramphenicol2 |
Eye oint 1%; 5 g tube |
$1.55 |
$1.09 |
Devatis (Devatis) |
5% |
1 July 2022 |
1 December 2022 |
|
Colchicine |
Tab 500 mcg; 100 tablet bottle |
$10.06 |
$6.00 |
Colgout (Aspen) |
5% |
1 April 2022 |
1 September 2022 |
|
Compound electrolytes |
Powder for oral soln; 50 sachet |
$9.77 |
$9.53 |
Electral (Teva) |
5% |
1 July 2022 |
1 December 2022 |
|
Cyclizine lactate2 |
Inj 50 mg per ml, 1 ml ampoule; 10 ampoule pack |
$21.53 |
$16.36 |
Hameln (Max Health) |
5% |
1 July 2022 |
1 December 2022 |
|
Dihydrocodeine tartrate |
Tab long-acting 60 mg; 60 tablet |
$8.60 |
$8.60 |
DHB Continus |
5% |
1 July 2022 |
1 December 2022 |
|
Dimethicone |
Crm 5% tube; 100 g tube |
$1.53 |
$1.47 |
healthE Dimethicone 5% |
5% |
1 July 2022 |
1 December 2022 |
|
Dimethicone |
Crm 5% pump bottle; 500 ml |
$4.48 |
$4.30 |
healthE Dimethicone 5% |
5% |
1 July 2022 |
1 December 2022 |
|
Dimethicone |
Lotn 4%; 200 ml bottle |
$4.98 |
$4.25 |
healthE Dimethicone 4% |
5% |
1 July 2022 |
1 December 2022 |
|
Erythromycin (as lactobionate) |
Inj 1 g vial; 1 vial pack |
$10.00 |
$10.00 |
Erythromycin IV (AFT) |
5% |
1 July 2022 |
1 December 2022 |
|
Glatiramer acetate2 |
Inj 40 mg prefilled syringe; 12 |
$2,275.00 |
$1,137.48 |
Copaxone (Teva) |
5% |
1 May 2022 |
1 October 2022 |
|
Lisinopril2 |
Tab 5 mg; 90 tablet blister pack |
$17.50 |
$11.07 |
Ethics Lisinopril (Teva) |
5% |
1 May 2022 |
1 October 2022 |
|
Lisinopril2 |
Tab 10 mg; 90 tablet blister pack |
$17.50 |
$11.67 |
Ethics Lisinopril (Teva) |
5% |
1 May 2022 |
1 October 2022 |
|
Lisinopril2 |
Tab 20 mg; 90 tablet blister pack |
$17.50 |
$14.69 |
Ethics Lisinopril (Teva) |
5% |
1 May 2022 |
1 October 2022 |
|
Mercaptopurine |
Tab 50 mg; 25 tablet bottle |
$37.00 |
$25.90 |
Puri-nethol (Aspen) |
5% |
1 July 2022 |
1 December 2022 |
|
Methenamine (hexamine) |
Tab 1 g; 100 tablet bottle |
$40.01 |
$19.95 |
Hiprex (Radiant Health) |
5% |
1 April September 2022 |
1 September 2022 February 2023 |
|
Montelukast |
Tab 4 mg; 28 tablet blister pack |
$4.25 |
$3.10 |
Montelukast Mylan (Viatris) |
5% |
1 July 2022 |
1 December 2022 |
|
Montelukast |
Tab 5 mg; 28 tablet blister pack |
$4.25 |
$3.10 |
Montelukast Mylan (Viatris) |
5% |
1 July 2022 |
1 December 2022 |
|
Montelukast |
Tab 10 mg; 28 tablet blister pack |
$3.95 |
$2.90 |
Montelukast Mylan (Viatris) |
5% |
1 July 2022 |
1 December 2022 |
|
Nimodipine |
Tab 30 mg; 100 tablet blister pack |
$350.00 |
$350.00 |
Nimotop (Bayer) |
5% |
1 July 2022 |
1 December 2022 |
|
Olopatadine2 |
Eye drops 0.1%; 5 ml bottle |
$2.20 |
$2.17 |
Olopatadine Teva (Teva) |
5% |
1 July 2022 |
1 December 2022 |
|
Pramipexole hydrochloride2 |
Tab 0.25 mg; 100 tablet blister |
$6.12 |
$5.51 |
Ramipex (Devatis) |
5% |
1 July 2022 |
1 December 2022 |
|
Pramipexole hydrochloride2 |
Tab 1 mg; 10 tablet blister pack |
$20.73 |
$18.66 |
Ramipex (Devatis) |
5% |
1 July 2022 |
1 December 2022 |
|
Promethazine hydrochloride |
Tab 10 mg; 50 tablet blister pack |
$2.02 |
$1.39 |
Allersoothe (AFT) |
5% |
1 April 2022 |
1 September 2022 |
|
Promethazine hydrochloride |
Tab 25 mg; 50 tablet blister pack |
$2.27 |
$1.58 |
Allersoothe (AFT) |
5% |
1 April 2022 |
1 September 2022 |
|
Sodium hyaluronate |
Inj 10 mg per ml, 0.85 ml syringe; |
$28.50 |
$28.50 |
Healon (AMO) |
5% |
1 July 2022 |
1 December 2022 |
|
Sodium hyaluronate |
Inj 18 mg per ml, 0.85 ml syringe; |
$50.00 |
$50.00 |
Healon GV Pro (AMO) |
5% |
1 July 2022 |
1 December 2022 |
|
Sodium hyaluronate |
Inj 23 mg per ml, 0.6 ml syringe; |
$60.00 |
$60.00 |
Healon 5 (AMO) |
5% |
1 July 2022 |
1 December 2022 |
|
Spironolactone |
Tab 25 mg; 100 tablet bottle |
$4.38 |
$3.68 |
Spiractin (Viatris) |
5% |
1 April 2022 |
1 September 2022 |
|
Spironolactone |
Tab 100 mg; 100 tablet bottle |
$11.80 |
$10.65 |
Spiractin (Viatris) |
5% |
1 April 2022 |
1 September 2022 |
|
2This product will be supplied at the Price from the 1st day of the month prior to the listing date, as per Schedule 6, clause 3.1 (b)(II) of the 2021/22 Invitation To Tender. 3The price and subsidy of carmustine (PCT only – Specialist) in Section B of the Pharmaceutical Schedule will also be amended to the above prices from 1 April 2022. The subsidy of carmustine (Baxter) inj 100 mg for ECP in Section B of the Pharmaceutical Schedule will also be amended from $1,387.00 per 100 mg to $710.00 per 100 mg from 1 April 2022. |
|||||||
5. Tenders awarded to pharmaceuticals where at least one other brand is listed
|
Chemical name |
Presentation; |
Current pack price |
New pack price |
Principal Supply brand |
DV limit |
Listing date |
Principal Supply date |
Brand (Supplier) affected by delisting |
|---|---|---|---|---|---|---|---|---|
|
Carmustine3 |
Inj 100 mg vial; 1 vial pack |
$1,387.00 |
$710.00 |
BiCNU (Luminarie) |
5% |
1 April 2022 |
1 September 2022 |
Bicnu Heritage (Luminarie) |
|
3The price and subsidy of carmustine (PCT only – Specialist) in Section B of the Pharmaceutical Schedule will also be amended to the above prices from 1 April 2022. The subsidy of carmustine (Baxter) inj 100 mg for ECP in Section B of the Pharmaceutical Schedule will also be amended from $1,387.00 per 100 mg to $710.00 per 100 mg from 1 April 2022. |
||||||||
Tender declines - Products where no tender is to be awarded for Principal Supply Status
Pharmac has resolved not to award tenders for Principal Supply Status for the following products listed in the 2021/22 Invitation to Tender, dated 1 November 2021.
|
Chemical name |
Line item |
|---|---|
|
Adapalene |
Crm 0.1% |
|
Adapalene |
Gel 0.1% |
|
Benzoyl peroxide |
Gel/crm/soln/lotion 2.5% - 5% |
|
Daunorubicin |
Inj 2 mg per ml, 10 ml |
|
Eptifibatide |
Inj 0.75 mg per ml, 100 ml |
|
Eptifibatide |
Inj 2 mg per ml, 25 ml |
|
Furosemide [Frusemide] |
Inj 10 mg per ml, 25 ml |
|
Furosemide [Frusemide] |
Oral liq 10 mg per ml |
|
Gentamicin sulphate |
Inj 40 mg per ml, 2 ml |
|
Isoniazid |
Tab 100 mg |
|
Isoniazid |
Tab 300 mg |
|
Lidocaine [Lignocaine] hydrochloride with chlorhexidine |
Gel 2% with 0.0% chlorhexidine, 10 ml urethral syringe |
|
Mercaptopurine |
Oral liq 20 mg per ml |
|
Mifepristone |
Tab 200 mg |
|
Mifepristone with misoprostol |
Mifepristone 200 mg tablet x 1 and misoprostol 200 mcg tablet x4 [combination pack] |
|
Morphine hydrochloride |
Oral liq 1 mg per ml |
|
Morphine hydrochloride |
Oral liq 2 mg per ml |
|
Morphine hydrochloride |
Oral liq 5 mg per ml |
|
Morphine hydrochloride |
Oral liq 10 mg per ml |
|
Oxybutynin |
Oral liq 1 mg per ml |
|
Prazosin hydrochloride |
Tab 1 mg |
|
Prazosin hydrochloride |
Tab 2 mg |
|
Prazosin hydrochloride |
Tab 5 mg |
|
Sodium fluoride |
Tab 1.1 mg |
|
Sodium hyaluronate [hyaluronic acid] |
Inj 14 mg per ml, 0.85 ml syringe |
|
Solifenacin succinate |
Oral liq |
|
Spironolactone |
Oral liq 5 mg per ml |
For products included in the 2019/20 and 2020/21 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to Pharmac Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.
If you have any queries regarding this notification, please contact Pharmac on 0800 66 00 50.